Fred Henry

Fred Henry, MS, MPH, is a seasoned regulatory professional currently serving as the Senior Director of Global Regulatory Affairs at Amgen. With extensive experience in regulatory leadership at prominent companies such as AbbVie, Taisho Pharmaceutical R&D, and Merck, Fred has played key roles in global product strategy and regulatory affairs. Fred’s educational background includes a Bachelor of Science in Chemistry from Rutgers University, a Master of Public Health from the University of Medicine and Dentistry of New Jersey, and a Master of Science in Management of Technology from Lehigh University.